Home » Press Release » 2013 » May 16, 2013

May 16, 2013

Alethia Biotherapeutics Announces the Issuance of a United States Patent for Monoclonal Antibodies Targeting Secreted Clusterin for Inhibition of EMT

Alethia 130516 EN